<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210518051337N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-27</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of delayed primary esophageal repair in patients with long gap esophageal atresia with primary esophageal replacement.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of delayed primary esophageal anastomosis in patients with long gap esophageal atresia with primary esophageal replacement by gastric pull up sugery.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56519</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Among neonates with esophageal atresia without fistula who have the inclusion criterias to enter the study, all patients with parental consent are admitted to the study in non-randomly manner. Then random division is done between study groups. In this study, a simple random allocation method using the RandList 1.2 function of Excel software is used as a tool for randomization. 1 group of delayed treatment and 2 group of neonatal surgery.In the randomization process for allocation concealment.</study_design>
      <phase>2</phase>
      <hc_freetext>esophgeal atresia without fistula.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: delayed  repair by primary anastomosis The first group received delayed intervention.the newborns with type A LGEA, the first surgical intervention was placement of gastrostomy tube through an open surgery. A  tube was used as the gastrostomy and in order to prevent aspiration, proximal pouch of the esophagus was repeatedly suctioned via a nasogastric or orogastric tube. Twenty days after the gastrotomy, an esophagoscope or bogie was inserted through the proximal pouch of esophagus and a bougie was inserted into the distal pouch of esophagus via gasterostomy, afterwards, the gap length between the proximal and distal esophageal pouch was measured by taking a radiograph. If the gap length was less than 2 cm, a primary esophageal anastomosis was performed immediately through right posterolateral thoracotomy. However, if the gap length was more than 2 cm, watchful waiting would have been continued and evaluation of the gap length was delayed for 20-30 days later. Esophageal reconstruction was delayed until the proper gap length was achieved. In first 3 months after birth, if there were any evidences of development and the gap length decrease to less than 2 cm (or less than the length of two vertebral bodies), delayed esophageal anastomosis was performed. Outcomes of this procedure was then evaluated considering the side effects such as pulmonary infections and sepsis occurring during the watchful waiting. The watchful waiting of the infant was done for 4 months after the esophageal reconstruction. Intervention 2: Control group: Gastric pull-up surgery in the neonatal period. The second group received primary intervention. In this group, in order to replace a section of underdeveloped esophagus with reconstructed stomach tissue, gastric pull up surgery was performed by the midline lapatomy and release of gastric tissue in the base of right gastric and gastroepipoloic arteries and gastric pull-up through the hiatus diapgragm and anastomosis through the right sided neck or right thorax cavity to the proximal pouch of esophgus. After the surgery, parenteral feeding was done until the patient was able to tolerate normal oral diet.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>nazila Hasan zadeh Ghavifekr</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Gholshar- Ghole yakh st. 22</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5167858549</zip>
        <telephone>+98 41 3385 1683</telephone>
        <email>nazila.hasanzadeh@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Saeid AslanAbadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>sheshgelan st. Tabriz childrens' Hospital</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5136735886</zip>
        <telephone>+98 41 3526 2250</telephone>
        <email>aslanabadis@hotmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Long gap congenital esophageal atresia</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>5 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>presence of gastric air in postnatal x-ray
prior esophagostomy before enterance to study
suspicious upper pouch fistula
Other severe congenital anomalies with unstable general condition</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Q39.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Atresia of esophagus without tracheo-esophageal fistula</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: delayed  repair by primary anastomosis The first group received delayed intervention.the newborns with type A LGEA, the first surgical intervention was placement of gastrostomy tube through an open surgery. A  tube was used as the gastrostomy and in order to prevent aspiration, proximal pouch of the esophagus was repeatedly suctioned via a nasogastric or orogastric tube. Twenty days after the gastrotomy, an esophagoscope or bogie was inserted through the proximal pouch of esophagus and a bougie was inserted into the distal pouch of esophagus via gasterostomy, afterwards, the gap length between the proximal and distal esophageal pouch was measured by taking a radiograph. If the gap length was less than 2 cm, a primary esophageal anastomosis was performed immediately through right posterolateral thoracotomy. However, if the gap length was more than 2 cm, watchful waiting would have been continued and evaluation of the gap length was delayed for 20-30 days later. Esophageal reconstruction was delayed until the proper gap length was achieved. In first 3 months after birth, if there were any evidences of development and the gap length decrease to less than 2 cm (or less than the length of two vertebral bodies), delayed esophageal anastomosis was performed. Outcomes of this procedure was then evaluated considering the side effects such as pulmonary infections and sepsis occurring during the watchful waiting. The watchful waiting of the infant was done for 4 months after the esophageal reconstruction.</i_keyword>
      <i_keyword>Control group: Gastric pull-up surgery in the neonatal period. The second group received primary intervention. In this group, in order to replace a section of underdeveloped esophagus with reconstructed stomach tissue, gastric pull up surgery was performed by the midline lapatomy and release of gastric tissue in the base of right gastric and gastroepipoloic arteries and gastric pull-up through the hiatus diapgragm and anastomosis through the right sided neck or right thorax cavity to the proximal pouch of esophgus. After the surgery, parenteral feeding was done until the patient was able to tolerate normal oral diet.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Decrease of the gap between upper and lower pouch os esophagus. Timepoint: initially two weeks after birth and then continuously every 20 days. Method of measurement: measurement of distance between upper and lower pouch of esophagus with opaque bogie under anesthesia and evaluation of therapeutic result and complications with checklist.</prim_outcome>
      <prim_outcome>Short term and long term complicayions of surgery. Timepoint: during operation, inthe post operation period, 2 month later, 4 month later. Method of measurement: clinical and radiologic signs of complications such as anastomosis leak, pneumonia, sepsis, stricture and reflux.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The ability to save and reconstruct the own esophagus of patient. Timepoint: n the operative procedure. Method of measurement: the operation Feasibility.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-29</approval_date>
        <contact_name>Research Ethics Committees of Tabriz University of Medical Sciences	Evaluated by: Ap</contact_name>
        <contact_address>Tabriz University of Medical Sciences., Golgasht St., Azadi St Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
